Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pierre A. Zalloua, Ph.D.

Concepts

This page shows the publications Pierre Zalloua has written about Prevalence.
Connection Strength

0.159
  1. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon. J Infect Dev Ctries. 2014 Mar 13; 8(3):339-48.
    View in: PubMed
    Score: 0.044
  2. WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. Hum Mol Genet. 2008 Dec 15; 17(24):4012-21.
    View in: PubMed
    Score: 0.030
  3. Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon. J Clin Virol. 2008 Feb; 41(2):166-7.
    View in: PubMed
    Score: 0.028
  4. Host and environmental factors defining the epidemiology of type 1 diabetes mellitus in a group of Lebanese children and young adults. J Pediatr Endocrinol Metab. 2003 Jun; 16(5):759-69.
    View in: PubMed
    Score: 0.021
  5. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol. 2002; 23(5):429-32.
    View in: PubMed
    Score: 0.019
  6. Prenatal and neonatal Group B Streptococcus screening and serotyping in Lebanon: incidence and implications. Acta Obstet Gynecol Scand. 2010 Mar; 89(3):399-403.
    View in: PubMed
    Score: 0.008
  7. Prevalence of asthmatic symptoms in Lebanese patients with type 1 diabetes and their unaffected siblings compared to age-matched controls. Acta Diabetol. 2010 Dec; 47 Suppl 1:13-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.